Use of drugs that act on the cytochrome p450 system in the elderly

Clinics

Volumn 64, Issue 4, 2009, Pages 273-278

  Cabrera, Marcos A S ^a   Dip, Renata M ^a   Furlan, Maira O ^a   Rodrigues, Sara L ^a  

^a STATE UNIVERSITY OF LONDRINA   (Brazil)

Author keywords

Aged; Cytochrome P450; Drug utilization; Drug drug interaction; Pharmacoepidemiology

Indexed keywords

CYTOCHROME P450; ENZYME INHIBITOR;

AGE DISTRIBUTION; AGED; ANALYSIS OF VARIANCE; ARTICLE; CHI SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDY; DRINKING BEHAVIOR; DRUG ANTAGONISM; DRUG EFFECT; DRUG INTERACTION; ENZYME INDUCTION; ENZYMOLOGY; FEMALE; HUMAN; LIVER; MALE; METABOLISM; SEX RATIO; SMOKING;

AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ALCOHOL DRINKING; ANALYSIS OF VARIANCE; CHI-SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDIES; CYTOCHROME P-450 ENZYME SYSTEM; DRUG INTERACTIONS; ENZYME INDUCTION; ENZYME INHIBITORS; FEMALE; HUMANS; LIVER; MALE; SEX DISTRIBUTION; SMOKING;

EID: 67650572201     PISSN: 18075932     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1807-59322009000400002     Document Type: Article

References (28)

1. Fialová D, Topinková E, Gambassi G, Finne-Soveri H, Jónsson PV, Carpenter I, et al. Potentially Inappropriate Medication Use Among Elderly Home Care Patients in Europe. JAMA. 2005;293:1348-58.
2. Kinirons MT, O'Mahony OS. Drug metabolism and ageing. Br J Clin Pharmacol. 2004;57(5):540-4.
3. Wauthier V, Verbeeck RK, Calderon PB. The effect of ageing on cytochrome p450 enzymes: consequences for drug biotransformation in the elderly. Curr Med Chem. 2007;14(7):745-57.
4. Tulner LR, Frankfort SV, Gijsen GJPT, van Campen JPCM, Koks CHW, Beijnen JH. Drug-drug interactions in a geriatric outpatient cohort. Drugs Aging. 2008;25(4):343-55.
5. Sandison NB. Drug interaction casebook: the cytochrome P450 system and beyond. Rio de Janeiro: Med line; 2007. p 1 a 7.
6. Lynch T, Price A. The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects. 2007. 1;76(3):391-6.
7. Pugh MJOV, Hanlon JT, Zeber JE, Bierman A, Cornell J, Berlowitz DR. Assessing Potentially Inappropriate Prescribing in the Elderly Veterans Affairs Population Using the HEDIS 2006 Quality Measure. J Manag Care Pharm. 2006;12(7):537-45.
8. Johnell K, Fastbom J, Rosén M, Leimanis A. Inappropriate drug use in the elderly: a nationwide register-based study. Ann Pharmacother. 2007;41(7):1243-8.
9. Cozza KL, Amrstrong SC, Oesterheld JR. Concise guide to drug interaction principles for medical practice: cytochrome P450, UGTs, P-glycoproteins. Arlington: American Psychiatric Publishing; 2003.
10. Haider SI, Johnell K, Thorslund M, Fastbom J. Trends in polypharmacy and potential drug-drug interactions across educational groups in elderly patients in Sweden for the period 1992 - 2002. Int J Clin Pharmacol Ther. 2007;45(12):643-53.
11. Mulder H, Heerdink ER, van Lersel EE, Wilmink FW, Egberts ACG. Prevalence of patients using drugs metabolized by cytochrome P450 2D6 in different populations: a cross-sectional study. Ann Pharmacother. 2007;41:408-13.
12. Classen S, Meuleman J, Garvan C, Ried LD, Mann W, Asal N. Review of prescription medications in home-based older adults with stroke: a pilot study. Res Social Adm Pharm. 2007;3(1):104-22.
13. Eichelbaum M, Evert B. Influence of pharmacogenetics on drug disposition and response. Clin Exp Pharmacol Physiol. 1996;23:983-5.
14. Mallet L, Spinewine A, Huang A. The challenge of managing drug interactions in elderly people. Lancet. 2007;370(14):185-91.
15. Anderson GD. Gender differences in pharmacological response. Int Rev Neurobiol. 2008;83:1-10.
16. Egger SS, Rätz Bravo AE, Hess L, Schlienger RG, Krähenbühl S. Age-related differences in the prevalence of potential drug-drug interactions in ambulatory dyslipidaemic patients treated with statins. Drugs Aging. 2007;24(5):429-40.
17. Cheng PY, Morgan ET. Hepatic cytochrome P450 regulation in disease states. Curr Drug Metab. 2001;2(2):165-83.
18. Johnell K, Klarin I. The relationship between number of drugs and potential drug-drug interactions in the elderly: a study of over 600,000 elderly patients from the Swedish Prescribed Drug Register. Drug Saf. 2007;30(10):911-8.
19. Cabrera MAS, Mesas AE, Rossato LA, Andrade SM. Salivary flow and psychoactive drug consumption in elderly people. Rev Assoc Med Bras. 2007;53(2):178-81.
20. Rossi MI, Young A, Maher R, Rodriguez KL, Appelt CJ, Perera S, et al. Polypharmacy and health beliefs in older outpatients. Am J Geriatr Pharmacother. 2007;5(4):317-23.
21. Coelho Filho JM, Marcopito LF, Castelo A. Medication use patterns among elderly people in urban area in Northeastern Brazil. Rev Saúde Pública. 2004;38(4):557-64.
22. Ribeiro AQ, Rozenfeld S, Klein CH, César CC, Acurcio FA. Survey on medicine use by elderly retirees in Belo Horizonte, Southeastern Brazil. Rev Saude Publica. 2008; 42(4):724-32.
23. Johnell K, Fastbom J. Multi-dose drug dispensing and inappropriate drug use: A nationwide register-based study of over 700,000 elderly. Scand J Prim Health Care. 2008;26(2):86-91.
24. Spina E, Scordo MG. Clinically significant drug interactions with antidepressants in the elderly. Drugs Aging. 2002;19(4):299-320.
25. Levy RH, Collins C. Risk and predictability of drug interactions in the elderly. Int Rev Neurobiol. 2007;81:235-51.
26. Gurley BJ, Gardner SF, Hubbard MA, Williams DK, Gentry WB, Cui Y, et al. Clinical assessment of effects of botanical supplementation on cytochrome P450 phenotypes in the elderly. Drugs Aging. 2005;22(6):525-39.
27. Cruciol-Souza JM, Thomson JC. A pharmacoepidemiologic study of drug interactions in a Brazilian teaching hospital. Clinics. 2006;61(6):515-20.
28. Gurwitz JH, Field TS, Harrold LR, Rothschild J, Debellis K, Seger AC, et al. Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA. 2003;289:1107-16.